Articles From: Japanese stocks retreat as oil continues to fall to JBL® Announces the World's First Headphone to Control Audio with a Wave of the Hand


2015/1/13
By Laura He, MarketWatch Hong Kong, Shanghai rise as Chinese exports beat estimates HONG KONG (MarketWatch) -- Japanese stocks snapped a three-session winning streak on Tuesday, as oil stocks led the index lower on a renewed drop in crude prices.
Sign-up for Japanese stocks retreat as oil continues to fall investment picks
2015/1/29
By Laura He, MarketWatch Chinese stocks fall on another round of margin-trade crackdown HONG KONG (MarketWatch) -- Japanese stocks fell Thursday, as investors worried about disappointing corporate earnings and as they absorbed signs the U.S. Federal Reserve is sticking to its timing on an increase in interest rates.
Sign-up for Japanese stocks retreat on earnings, Fed rate-hike concerns investment picks
2015/2/12
By Kosaku Narioka TOKYO--Japanese stocks hit a seven-year high Thursday, propelled by upbeat earnings outlooks and shareholder friendly moves by companies.
Sign-up for Japanese Stocks Rise on Upbeat Earnings Outlooks investment picks
2015/2/3
By Takashi Mochizuki TOKYO--Japanese TV makers, suffering from a steep drop in sales reflected in earnings reports Tuesday from Sharp Corp.
Sign-up for Japanese TV Makers Retreat From Overseas Markets -- Update investment picks
2015/1/20
Provides Initial 2015 Guidance MIAMI , Jan.
Sign-up for Jarden Announces Preliminary Fourth Quarter And Full Year 2014 Results investment picks
2015/2/12
Record Fourth Quarter Net Sales of $2.44 Billion Record Fourth Quarter Organic Net Sales Growth of 11.4% Record Fourth Quarter Segment Earnings of $411 Million and Margin of 16.8% Fourth Quarter Adjusted Diluted Earnings per Share Increases 32% to $1.15 MIAMI , Feb.
Sign-up for Jarden Reports Fourth Quarter and 2014 Full Year Results investment picks
2015/1/5
JLT Specialty Insurance Services Inc. (“JLT Specialty USA”), a US subsidiary of Jardine Lloyd Thompson Group plc.
Sign-up for Jardine Lloyd Thompson US Specialty Business Appoints Further Energy Specialists to Form Market Leading Energy Capability investment picks
2015/2/24
Provides Fiscal 2015 Revenue and Adjusted EBITDA Outlook MILWAUKEE, Feb.
Sign-up for Jason Industries Reports Fourth Quarter and Full Year 2014 Results investment picks
2015/1/20
MILWAUKEE, Jan.
Sign-up for Jason Industries to Hold Annual Meeting of Stockholders on May 20 investment picks
2014/12/19
MILWAUKEE, Dec.
Sign-up for Jason Industries, Inc. Announces Dividend on Preferred Stock investment picks
2015/2/2
COLUMBUS, Ohio , Feb.
Sign-up for Jason Paduchik Named AT&T Senior Director Of Legislative Affairs For Ohio investment picks
2014/12/22
VERO BEACH, Fla., Dec.
Sign-up for JAVELIN Mortgage Investment Corp. Announces Monthly Dividend Rate for Q1 2015 investment picks
2015/1/2
VERO BEACH, Fla., Jan.
Sign-up for JAVELIN Mortgage Investment Corp. Confirms Monthly Dividend Rate for Q1 2015 investment picks
2014/12/17
WALTHAM, Mass.
Sign-up for Jay B. Stephens to Retire From Raytheon Company investment picks
2015/1/29
Evercore (NYSE:EVR) announced today that Jay Chandler has joined the Firm’s Investment Banking business as a Senior Managing Director in its Equity Capital Markets Group and will be based in Evercore’s office in New York.
Sign-up for Jay Chandler Has Joined Evercore as a Senior Managing Director in Its Equity Capital Markets Group investment picks
2014/12/30
Jay Rasulo, senior executive vice president and chief financial officer, The Walt Disney Company (NYSE: DIS), will participate in a question-and-answer session at the Citi 2015 Internet, Media and Telecommunications Conference on Tuesday, January 6, 2015 at approximately 5:00 p.m. EST / 2:00 p.m. PST.
Sign-up for Jay Rasulo, Senior Executive Vice President and Chief Financial Officer, The Walt Disney Company, to Speak at the Citi 2015 Internet, Media and Telecommunications Conference investment picks
2014/12/9
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) and Concert Pharmaceuticals, Inc .
Sign-up for Jazz Pharmaceuticals and Concert Pharmaceuticals Provide JZP-386 Program Update investment picks
2014/12/2
Trial Initiated in Response to a FDA Pediatric Written Request to Study Xyrem in Children and Adolescents DUBLIN , Dec.
Sign-up for Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Trial of Xyrem® (Sodium Oxybate) In Children And Adolescents Who Have Narcolepsy With Cataplexy investment picks
2015/2/24
Company Reports Total Revenues of $1.17 Billion in 2014 Driven by Strong Sales of Xyrem, Erwinaze and Defitelio Adjusted EPS of $8.43 and GAAP EPS of $0.93 in 2014 DUBLIN , Feb.
Sign-up for Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2014 Financial Results investment picks
2015/2/23
DUBLIN , Feb.
Sign-up for Jazz Pharmaceuticals Announces Participation in Two Investor Conferences in March investment picks
2014/12/11
Expects to complete submission in the first half of 2015 DUBLIN , Dec.
Sign-up for Jazz Pharmaceuticals Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Disease investment picks
2014/12/19
Expanded U.S. Labeling Offers an Alternative Method to Administer Erwinaze to Patients with ALL DUBLIN , Dec.
Sign-up for Jazz Pharmaceuticals Receives FDA Approval For Intravenous Administration Of Erwinaze® (asparaginase Erwinia chrysanthemi) investment picks
2015/1/5
DUBLIN , Jan.
Sign-up for Jazz Pharmaceuticals to Present at J.P. Morgan Healthcare Conference on January 12 investment picks
2015/2/12
Three Oral Presentations Provide New Analyses of the Efficacy and Safety of Defibrotide in Patients with VOD, Including Post-Hoc Sub-Group Analyses in Children, Adults, and Allograft and Autograft Recipients DUBLIN , Feb.
Sign-up for Jazz Pharmaceuticals to Present Data on Defibrotide, an Investigational Treatment, in Patients with Hepatic Veno-Occlusive Disease (VOD) at BMT Tandem Meetings investment picks
2014/12/2
Posters Include an Epidemiological Measure of the Effectiveness Analysis of Defibrotide from a Phase 3 Trial in Severe Hepatic VOD, as well as Updates from an International Compassionate Use Program and a U.S. Treatment IND Study DUBLIN , Dec.
Sign-up for Jazz Pharmaceuticals To Present New Analysis Of Defibrotide Data In Patients With Hepatic Veno-Occlusive Disease (VOD) At ASH Annual Meeting investment picks
2015/1/30
Jazz pilots ratify 11 year tentative agreement Canada NewsWire HALIFAX , Jan.
Sign-up for Jazz pilots ratify 11 year tentative agreement investment picks
2015/1/5
The JBL S700NC brings the same professional audio sound to personal listening as the original JBL S700, but now that experience is enhanced by active noise cancelling performance and patented Clari-Fi™ technology.
Sign-up for JBL® Announces the World's First headphone featuring HARMAN's exclusive Clari-Fi™ technology with ANC investment picks
2015/1/5
Crossing into unprecedented territory, JBL award-winning headphones feature innovative technology with motion sensor controls that will keep you active with best-in-class JBL audio LAS VEGAS , Jan.
Sign-up for JBL® Announces the World's First Headphone to Control Audio with a Wave of the Hand investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Japanese stocks retreat as oil continues to fall to JBL® Announces the World's First Headphone to Control Audio with a Wave of the Hand
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent